Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer
CANCER RESEARCH UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced...








